Symbols

Symbols

Aime

Products

News

Markets

Watchlist

Brokers

News/

Stock/

NRXP

NRXP News

Newswire

20:27

NRx Pharmaceuticals Expands NRX-101 Use for Depression Treatment with TMS

20:27

NRXP: BTIG Reiterates Buy Rating, Price Target Unchanged

15:31

NRX Pharmaceuticals: D. Boral Capital Raises Buy Rating, PT to $34 from $34.

14:41

NRx Pharmaceuticals Amends IND to Advance NRX-101 for Depression Treatment with TMS

13:32

BTIG Reaffirms Buy Recommendation for NRx Pharmaceuticals, Sees 1,540.09% Upside

View More

About NRXP

Charts

--

Sector--

Established Date--

Listing Date--

Exchange--

Full-time Employees--

Fiscal Year Ends--

Website

Security Type--

Office address

Business

Introduction

View More